Last 12 months
Inside the activity.
1 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2024 Filed Jan 4, 2024 17:07 UTC |
Brunn CarstenDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,971,000 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0001453687-24-000025 · wk-form4_1704406045.xml · derivative · entry 2 Brunn Carsten · CIK 0001760229 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,971,000 Underlying: Common Stock · 5,971,000 shares Expires 2034-01-01 F2 · derivative.exercise_date: This option vests as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2028. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 17:07 UTC |
Brunn CarstenDirector · President and CEO
|
GrantCommon Stock | 4,654,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001453687-24-000025 · wk-form4_1704406045.xml · nonDerivative · entry 1 Brunn Carsten · CIK 0001760229 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,916,056 F1 · kind: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2028. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 17:05 UTC |
DeSilva Nishan MDirector
|
GrantStock Option (Right to Buy) · Derivative | 228,000 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0001453687-24-000020 · wk-form4_1704405920.xml · derivative · entry 2 DeSilva Nishan M · CIK 0001492386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,000 Underlying: Common Stock · 228,000 shares Expires 2034-01-01 F2 · derivative.exercise_date: This award will vest in 36 equal monthly installments, so that it shall be fully vested on January 2, 2027. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 17:05 UTC |
DeSilva Nishan MDirector
|
GrantCommon Stock | 178,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001453687-24-000020 · wk-form4_1704405920.xml · nonDerivative · entry 1 DeSilva Nishan M · CIK 0001492386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,000 F1 · kind: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in three equal annual installments so that the underlying shares will be fully vested on January 2, 2027. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:12 UTC |
Singer MichaelDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 228,000 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0001453687-24-000028 · wk-form4_1704406322.xml · derivative · entry 8 Singer Michael · CIK 0002000122 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,000 Underlying: Common Stock · 228,000 shares Expires 2034-01-01 F8 · derivative.exercise_date: This award will vest in 36 equal monthly installments, so that it shall be fully vested on the third anniversary of the date of grant. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:12 UTC |
Singer MichaelDirector · 10% owner
|
GrantCommon Stock | 178,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001453687-24-000028 · wk-form4_1704406322.xml · nonDerivative · entry 1 Singer Michael · CIK 0002000122 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,123 F1 · kind: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in three equal annual installments so that the underlying shares will be fully vested on January 2, 2027. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:08 UTC |
Davis BlaineChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,110,000 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0001453687-24-000027 · wk-form4_1704406090.xml · derivative · entry 2 Davis Blaine · CIK 0001802188 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,110,000 Underlying: Common Stock · 3,110,000 shares Expires 2034-01-01 F2 · derivative.exercise_date: This option vests as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2028. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:08 UTC |
Davis BlaineChief Financial Officer
|
GrantCommon Stock | 2,424,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001453687-24-000027 · wk-form4_1704406090.xml · nonDerivative · entry 1 Davis Blaine · CIK 0001802188 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,424,000 F1 · kind: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2028. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:08 UTC |
Jewell Christopher MChief Scientific Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 998,000 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0001453687-24-000026 · wk-form4_1704406063.xml · derivative · entry 2 Jewell Christopher M · CIK 0002000226 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 998,000 Underlying: Common Stock · 998,000 shares Expires 2034-01-01 F2 · derivative.exercise_date: This option vests as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2028. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:08 UTC |
Jewell Christopher MChief Scientific Officer
|
GrantCommon Stock | 778,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001453687-24-000026 · wk-form4_1704406063.xml · nonDerivative · entry 1 Jewell Christopher M · CIK 0002000226 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 778,200 F1 · kind: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2028. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:07 UTC |
Sallin AymericDirector
|
GrantStock Option (Right to Buy) · Derivative | 228,000 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0001453687-24-000024 · wk-form4_1704406012.xml · derivative · entry 2 Sallin Aymeric · CIK 0001677660 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,000 Underlying: Common Stock · 228,000 shares Expires 2034-01-01 F2 · derivative.exercise_date: This award will vest in 36 equal monthly installments, so that it shall be fully vested on January 2, 2027. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:07 UTC |
Sallin AymericDirector
|
GrantCommon Stock | 178,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001453687-24-000024 · wk-form4_1704406012.xml · nonDerivative · entry 1 Sallin Aymeric · CIK 0001677660 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,000 F1 · kind: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in three equal annual installments so that the underlying shares will be fully vested on January 2, 2027. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:06 UTC |
BARABE TIMOTHY CDirector
|
GrantStock Option (Right to Buy) · Derivative | 228,000 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0001453687-24-000023 · wk-form4_1704405997.xml · derivative · entry 2 BARABE TIMOTHY C · CIK 0001237409 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,000 Underlying: Common Stock · 228,000 shares Expires 2034-01-01 F2 · derivative.exercise_date: This award will vest in 36 equal monthly installments, so that it shall be fully vested on January 2, 2027. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:06 UTC |
BARABE TIMOTHY CDirector
|
GrantCommon Stock | 178,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001453687-24-000023 · wk-form4_1704405997.xml · nonDerivative · entry 1 BARABE TIMOTHY C · CIK 0001237409 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 428,013 F1 · kind: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in three equal annual installments so that the underlying shares will be fully vested on January 2, 2027. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:06 UTC |
Miljkovic MilosChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 703,000 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0001453687-24-000021 · wk-form4_1704405942.xml · derivative · entry 2 Miljkovic Milos · CIK 0002000282 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 703,000 Underlying: Common Stock · 703,000 shares Expires 2034-01-01 F2 · derivative.exercise_date: This option vests as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:06 UTC |
Miljkovic MilosChief Medical Officer
|
GrantCommon Stock | 548,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001453687-24-000021 · wk-form4_1704405942.xml · nonDerivative · entry 1 Miljkovic Milos · CIK 0002000282 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 548,200 F1 · kind: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2028. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:04 UTC |
Kalayoglu MuratDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 228,000 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0001453687-24-000017 · wk-form4_1704405827.xml · derivative · entry 3 Kalayoglu Murat · CIK 0002000002 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,000 Underlying: Common Stock · 228,000 shares Expires 2034-01-01 F3 · derivative.exercise_date: This award will vest in 36 equal monthly installments, so that it shall be fully vested on January 2, 2027. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:04 UTC |
Kalayoglu MuratDirector · 10% owner
|
GrantCommon Stock | 178,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001453687-24-000017 · wk-form4_1704405827.xml · nonDerivative · entry 1 Kalayoglu Murat · CIK 0002000002 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 435,739 F1 · kind: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in three equal annual installments so that the underlying shares will be fully vested on January 2, 2027. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:03 UTC |
Kurtoglu MetinChief Operating Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 1,965,000 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0001453687-24-000016 · wk-form4_1704405809.xml · derivative · entry 2 Kurtoglu Metin · CIK 0002000284 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,965,000 Underlying: Common Stock · 1,965,000 shares Expires 2034-01-01 F2 · derivative.exercise_date: This option vests as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2028. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:03 UTC |
Kurtoglu MetinChief Operating Officer
|
GrantCommon Stock | 1,531,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001453687-24-000016 · wk-form4_1704405809.xml · nonDerivative · entry 1 Kurtoglu Metin · CIK 0002000284 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,531,000 F1 · kind: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2028. Read SEC document |
| December 22, 2023 Filed Jan 4, 2024 22:12 UTC |
Singer MichaelDirector · 10% owner
|
GiftSeries A Convertible Preferred Stock · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001453687-24-000028 · wk-form4_1704406322.xml · derivative · entry 9 Singer Michael · CIK 0002000122 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,304.559 Underlying: Common Stock · 3,000,000 shares Expires not disclosed F9 · derivative.exercise_price: Following the approval by the Stockholders of the conversion of the Series A Non-Voting Convertible Preferred Stock of the Company ("Series A Preferred Stock") into shares of common stock of the Company ("Common Stock"), each share of Series A Preferred Stock will be convertible into 1,000 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series A Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. F10 · kind: Bona fide gift to Yale University. F9 · derivative.exercise_date: Following the approval by the Stockholders of the conversion of the Series A Non-Voting Convertible Preferred Stock of the Company ("Series A Preferred Stock") into shares of common stock of the Company ("Common Stock"), each share of Series A Preferred Stock will be convertible into 1,000 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series A Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. F9 · derivative.expiration_date: Following the approval by the Stockholders of the conversion of the Series A Non-Voting Convertible Preferred Stock of the Company ("Series A Preferred Stock") into shares of common stock of the Company ("Common Stock"), each share of Series A Preferred Stock will be convertible into 1,000 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series A Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. Read SEC document |
| November 15, 2023 Filed Nov 15, 2023 22:20 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
GrantSeries A Convertible Preferred Stock | 123,925.407 | $403.47 | $49,999,998.07 |
DisclosureSEC source: 0001453687-23-000087 · wk-form4_1700086801.xml · nonDerivative · entry 2 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,925.407 Read SEC document |
| November 15, 2023 Filed Nov 15, 2023 22:20 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
GrantSeries A Convertible Preferred Stock | 24,785.081 | $403.47 | $9,999,999.45 |
DisclosureSEC source: 0001453687-23-000087 · wk-form4_1700086801.xml · nonDerivative · entry 1 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 24,785.081 F1 · ownership.nature: Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 22:20 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 75,000 | $0.93 Strike: $1.13 | $69,750.00 |
DisclosureSEC source: 0001453687-23-000087 · wk-form4_1700086801.xml · derivative · entry 12 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires 2033-01-01 F8 · derivative.exercise_date: This option, which provided for vesting in full on January 2, 2024, was canceled in the Merger in exchange for a cash payment of $69,750, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 22:20 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 40,000 | Not disclosed Strike: $3.31 | Not disclosed |
DisclosureSEC source: 0001453687-23-000087 · wk-form4_1700086801.xml · derivative · entry 11 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2032-01-02 F7 · price: This option, which provided for vesting in full on January 3, 2023, was canceled in the Merger. F7 · derivative.exercise_date: This option, which provided for vesting in full on January 3, 2023, was canceled in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 22:20 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 40,000 | Not disclosed Strike: $4.01 | Not disclosed |
DisclosureSEC source: 0001453687-23-000087 · wk-form4_1700086801.xml · derivative · entry 10 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2031-03-29 F6 · price: This option, which provided for vesting in full on March 30, 2022, was canceled in the Merger. F6 · derivative.exercise_date: This option, which provided for vesting in full on March 30, 2022, was canceled in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 22:20 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 20,000 | Not disclosed Strike: $3.00 | Not disclosed |
DisclosureSEC source: 0001453687-23-000087 · wk-form4_1700086801.xml · derivative · entry 9 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2030-06-18 F5 · price: This option, which provided for vesting in full on June 17, 2021, was canceled in the Merger. F5 · derivative.exercise_date: This option, which provided for vesting in full on June 17, 2021, was canceled in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 22:20 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 10,000 | Not disclosed Strike: $2.10 | Not disclosed |
DisclosureSEC source: 0001453687-23-000087 · wk-form4_1700086801.xml · derivative · entry 8 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2029-06-13 F4 · price: This option, which provided for vesting in full on June 14, 2020, was canceled in the Merger. F4 · derivative.exercise_date: This option, which provided for vesting in full on June 14, 2020, was canceled in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 22:20 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 10,000 | Not disclosed Strike: $12.75 | Not disclosed |
DisclosureSEC source: 0001453687-23-000087 · wk-form4_1700086801.xml · derivative · entry 7 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2028-06-14 F3 · price: This option, which provided for vesting in full on June 13, 2019, was canceled in the Merger. F3 · derivative.exercise_date: This option, which provided for vesting in full on June 13, 2019, was canceled in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 22:20 UTC |
SPRINGER TIMOTHY ADirector · 10% owner
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 6,410 | Not disclosed Strike: $17.47 | Not disclosed |
DisclosureSEC source: 0001453687-23-000087 · wk-form4_1700086801.xml · derivative · entry 6 SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,410 shares Expires 2027-06-15 F2 · price: This option, which provided for vesting in full on June 14, 2018, was canceled in the merger (the "Merger") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc. F2 · derivative.exercise_date: This option, which provided for vesting in full on June 14, 2018, was canceled in the merger (the "Merger") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 22:14 UTC |
COX CARRIE SMITHDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 107,500 | $0.93 Strike: $1.13 | $99,975.00 |
DisclosureSEC source: 0001453687-23-000081 · wk-form4_1700086481.xml · derivative · entry 5 COX CARRIE SMITH · CIK 0001110753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 107,500 shares Expires 2033-01-01 F5 · derivative.exercise_date: This option, which provided for vesting in full on January 2, 2024, was canceled in the Merger in exchange for a cash payment of $99,975, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 22:14 UTC |
COX CARRIE SMITHDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 60,000 | Not disclosed Strike: $3.31 | Not disclosed |
DisclosureSEC source: 0001453687-23-000081 · wk-form4_1700086481.xml · derivative · entry 4 COX CARRIE SMITH · CIK 0001110753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2032-01-02 F4 · price: This option, which provided for vesting in full on January 3, 2023, was canceled in the Merger. F4 · derivative.exercise_date: This option, which provided for vesting in full on January 3, 2023, was canceled in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 22:14 UTC |
COX CARRIE SMITHDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 60,000 | Not disclosed Strike: $4.01 | Not disclosed |
DisclosureSEC source: 0001453687-23-000081 · wk-form4_1700086481.xml · derivative · entry 3 COX CARRIE SMITH · CIK 0001110753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2031-03-29 F3 · price: This option, which provided for vesting in full on March 30, 2022, was canceled in the Merger. F3 · derivative.exercise_date: This option, which provided for vesting in full on March 30, 2022, was canceled in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 22:14 UTC |
COX CARRIE SMITHDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 30,000 | Not disclosed Strike: $3.00 | Not disclosed |
DisclosureSEC source: 0001453687-23-000081 · wk-form4_1700086481.xml · derivative · entry 2 COX CARRIE SMITH · CIK 0001110753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2030-06-18 F2 · price: This option, which provided for vesting in full on June 17, 2021, was canceled in the Merger. F2 · derivative.exercise_date: This option, which provided for vesting in full on June 17, 2021, was canceled in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 22:14 UTC |
COX CARRIE SMITHDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 20,000 | $0.74 Strike: $1.32 | $14,800.00 |
DisclosureSEC source: 0001453687-23-000081 · wk-form4_1700086481.xml · derivative · entry 1 COX CARRIE SMITH · CIK 0001110753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2029-11-19 F1 · derivative.exercise_date: This option, which provided for vesting in thirty-six (36) substantially equal monthly installments over three years following the date of grant on November 20, 2019, was canceled in the merger (the "Merger") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc. in exchange for a cash payment of $14,800, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 17:18 UTC |
ZENNER PATRICK JDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 75,000 | $0.93 Strike: $1.13 | $69,750.00 |
DisclosureSEC source: 0001453687-23-000085 · wk-form4_1700086687.xml · derivative · entry 7 ZENNER PATRICK J · CIK 0001139036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires 2033-01-01 F7 · derivative.exercise_date: This option, which provided for vesting in full on January 2, 2024, was canceled in the Merger in exchange for a cash payment of $69,750, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 17:18 UTC |
ZENNER PATRICK JDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 40,000 | Not disclosed Strike: $3.31 | Not disclosed |
DisclosureSEC source: 0001453687-23-000085 · wk-form4_1700086687.xml · derivative · entry 6 ZENNER PATRICK J · CIK 0001139036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2032-01-02 F6 · price: This option, which provided for vesting in full on January 3, 2023, was canceled in the Merger. F6 · derivative.exercise_date: This option, which provided for vesting in full on January 3, 2023, was canceled in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 17:18 UTC |
ZENNER PATRICK JDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 40,000 | Not disclosed Strike: $4.01 | Not disclosed |
DisclosureSEC source: 0001453687-23-000085 · wk-form4_1700086687.xml · derivative · entry 5 ZENNER PATRICK J · CIK 0001139036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2031-03-29 F5 · price: This option, which provided for vesting in full on March 30, 2022, was canceled in the Merger. F5 · derivative.exercise_date: This option, which provided for vesting in full on March 30, 2022, was canceled in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 17:18 UTC |
ZENNER PATRICK JDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 20,000 | Not disclosed Strike: $3.00 | Not disclosed |
DisclosureSEC source: 0001453687-23-000085 · wk-form4_1700086687.xml · derivative · entry 4 ZENNER PATRICK J · CIK 0001139036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2030-06-18 F4 · price: This option, which provided for vesting in full on June 17, 2021, was canceled in the Merger. F4 · derivative.exercise_date: This option, which provided for vesting in full on June 17, 2021, was canceled in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 17:18 UTC |
ZENNER PATRICK JDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 10,000 | Not disclosed Strike: $2.10 | Not disclosed |
DisclosureSEC source: 0001453687-23-000085 · wk-form4_1700086687.xml · derivative · entry 3 ZENNER PATRICK J · CIK 0001139036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2029-06-13 F3 · price: This option, which provided for vesting in full on June 14, 2020, was canceled in the Merger. F3 · derivative.exercise_date: This option, which provided for vesting in full on June 14, 2020, was canceled in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 17:18 UTC |
ZENNER PATRICK JDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 10,000 | Not disclosed Strike: $12.75 | Not disclosed |
DisclosureSEC source: 0001453687-23-000085 · wk-form4_1700086687.xml · derivative · entry 2 ZENNER PATRICK J · CIK 0001139036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2028-06-14 F2 · price: This option, which provided for vesting in full on June 13, 2019, was canceled in the Merger. F2 · derivative.exercise_date: This option, which provided for vesting in full on June 13, 2019, was canceled in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 17:18 UTC |
ZENNER PATRICK JDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 12,820 | Not disclosed Strike: $17.47 | Not disclosed |
DisclosureSEC source: 0001453687-23-000085 · wk-form4_1700086687.xml · derivative · entry 1 ZENNER PATRICK J · CIK 0001139036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,820 shares Expires 2027-06-15 F1 · price: This option, which provided for vesting in thirty-six (36) substantially equal monthly installments over three years following the date of grant on June 16, 2017, was canceled in the merger (the "Merger") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc. F1 · derivative.exercise_date: This option, which provided for vesting in thirty-six (36) substantially equal monthly installments over three years following the date of grant on June 16, 2017, was canceled in the merger (the "Merger") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 17:26 UTC |
Brunn CarstenDirector · President and CEO
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 1,275,000 | $0.93 Strike: $1.13 | $1,185,750.00 |
DisclosureSEC source: 0001453687-23-000088 · wk-form4_1700087164.xml · derivative · entry 13 Brunn Carsten · CIK 0001760229 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,275,000 shares Expires 2033-01-01 F13 · derivative.exercise_date: This option, which provided for vesting as to 25% of the shares on January 2, 2024 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger, in exchange for a cash payment of $1,185,750, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 17:26 UTC |
Brunn CarstenDirector · President and CEO
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 1,056,100 | Not disclosed Strike: $3.31 | Not disclosed |
DisclosureSEC source: 0001453687-23-000088 · wk-form4_1700087164.xml · derivative · entry 12 Brunn Carsten · CIK 0001760229 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,056,100 shares Expires 2032-01-02 F12 · price: This option, which provided for vesting as to 25% of the shares on January 3, 2023 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger. F12 · derivative.exercise_date: This option, which provided for vesting as to 25% of the shares on January 3, 2023 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 17:26 UTC |
Brunn CarstenDirector · President and CEO
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 163,000 | Not disclosed Strike: $4.32 | Not disclosed |
DisclosureSEC source: 0001453687-23-000088 · wk-form4_1700087164.xml · derivative · entry 11 Brunn Carsten · CIK 0001760229 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 163,000 shares Expires 2031-09-23 F11 · price: This option, which provided for vesting as to 25% of the shares on September 24, 2022 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger. F11 · derivative.exercise_date: This option, which provided for vesting as to 25% of the shares on September 24, 2022 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 17:26 UTC |
Brunn CarstenDirector · President and CEO
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 670,000 | Not disclosed Strike: $2.99 | Not disclosed |
DisclosureSEC source: 0001453687-23-000088 · wk-form4_1700087164.xml · derivative · entry 10 Brunn Carsten · CIK 0001760229 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 670,000 shares Expires 2031-01-03 F10 · price: This option, which provided for vesting as to 25% of the shares on January 4, 2022 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger. F10 · derivative.exercise_date: This option, which provided for vesting as to 25% of the shares on January 4, 2022 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 17:26 UTC |
Brunn CarstenDirector · President and CEO
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 75,000 | Not disclosed Strike: $2.84 | Not disclosed |
DisclosureSEC source: 0001453687-23-000088 · wk-form4_1700087164.xml · derivative · entry 9 Brunn Carsten · CIK 0001760229 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires 2030-06-30 F9 · price: This option, which provided for vesting as to 25% of the shares on July 1, 2021 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger. F9 · derivative.exercise_date: This option, which provided for vesting as to 25% of the shares on July 1, 2021 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 17:26 UTC |
Brunn CarstenDirector · President and CEO
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 600,000 | Not disclosed Strike: $2.30 | Not disclosed |
DisclosureSEC source: 0001453687-23-000088 · wk-form4_1700087164.xml · derivative · entry 8 Brunn Carsten · CIK 0001760229 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 600,000 shares Expires 2030-01-01 F8 · price: This option, which provided for vesting as to 25% of the shares on January 2, 2021 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger. F8 · derivative.exercise_date: This option, which provided for vesting as to 25% of the shares on January 2, 2021 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 17:26 UTC |
Brunn CarstenDirector · President and CEO
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 400,000 | $0.31 Strike: $1.75 | $124,000.00 |
DisclosureSEC source: 0001453687-23-000088 · wk-form4_1700087164.xml · derivative · entry 7 Brunn Carsten · CIK 0001760229 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 400,000 shares Expires 2029-10-06 F7 · derivative.exercise_date: This option, which provided for vesting as to 50% of the shares on October 7, 2020 and the remaining 50% of the shares on October 7, 2021, was canceled in the Merger, in exchange for a cash payment of $124,000, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 17:26 UTC |
Brunn CarstenDirector · President and CEO
|
Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 330,000 | Not disclosed Strike: $2.20 | Not disclosed |
DisclosureSEC source: 0001453687-23-000088 · wk-form4_1700087164.xml · derivative · entry 6 Brunn Carsten · CIK 0001760229 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 330,000 shares Expires 2029-02-24 F6 · price: This option, which provided for vesting as to 25% of the shares on February 25, 2020 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger. F6 · derivative.exercise_date: This option, which provided for vesting as to 25% of the shares on February 25, 2020 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.